Breast metastasis of small bowel carcinoid tumor misdiagnosed as primary breast cancer
To the Editor: Carcinoid tumors are rare, but constitute the most common gastrointestinal neur r roendocrine tumors. 1 These tur r mors arise from enterochromaffin cells of the gastrointestinal tract. Carcinoid syndrome occurs in apr r proximately 50% of patients with intestinal carcinoids and manifests as episodes of diarrhea, abdominal pain, and flushing. 2 Small intesr r tinal carcinoids metastasizing to the breast have only sporadically been reported in the literature. 3 Metastatic breast carcinoid can be easily mistaken for primary breast carcinoma. This may potentially be detrimental for the patient, esr r pecially if the primary surgery is a mastectomy with axillary lymph node dissection.
A 64ryearrold Caucasian female presented to her primary care phyr r sician with a chief complaint of left nipple pain. Mammogram showed a 2rcm solid mass in the lateral aspect of left breast suspicious for malignancy. Ultrasoundrguided bir r opsy showed papillary carcinoma. Subsequently, a staging CT scan showed multiple hypodense lesions throughout the liver consistent with metastatic disease. Biopsy of the largest lesion confirmed the metastatic nature of the disease.
Diagnosis of stage IV papillary carcinoma of the breast was made and the patient was started on bevr r acizumab and paclitaxel. Following her initial treatment, the patient remained in good performance status except that she continued to complain of worsening diarrhea and facial flushing, which she had had for the last seven years prior to the current disease and which was attributed to menopause. The persistent symptoms led the patient to seek a second opinr r ion at the Yale Cancer Center. An octreotide scan showed multiple areas of increased activity within the liver, abnormal accumulation in the lower abdomen, upper pelvis, left midthorax and mid frontal and left superior parietal region of the calvarium (Figure 1) .
Laboratory data showed inr r creased pancreatic polypeptide (347 pg/mL; normal, up to 80 pg/ mL) and serotonin (1448 ng/mL; normal, 101r283 ng/mL) levels. A previous breast biopsy was rer r viewed by the pathologist revealed a wellrdifferentiated infiltrating neuroendocrine carcinoma (NET). Synaptophysin and chromogranin were intensely and diffusely posir r tive confirming neuroendocrine difr r ferentiation (Figures 2, 3 ). Based on these findings, a diagnosis of NET of the small bowel was made with metastases to the liver and left breast. Lumpectomy of the breast was performed and chemotherapy was stopped. The patient has been treated with octreotide injection. Two years later, the patient is active and radiological imaging shows stable disease with no new areas of metastases.
Carcinoid tumors in the breast are rare. These tumors may occur as metastases from a known carr r cinoid tumor, or as a primary prer r sentation of a metastatic carcinoid tumor, or as a primary breast tur r mor (Table 1) . 4 Carcinoid tumors contain characteristic cytoplasmic granules that can be highlighted with special stains such as chror r mogranin, synaptophysin, or neur r ronrspecific enolase. 5 Patients with carcinoid tumor metastatic to the breast should undergo lumpector r my alone, with multiple resections if more than one lesion is present. Patients with primary breast carr r cinoid should be treated in a manr r ner similar to invasive ductal breast cancer that is appropriate for the size and stage of the lesion. 6 It is important to differentiate between primary breast carcinoma, primary breast carcinoid tumor and metar r static disease to the breast because of differences in treatment.
